G 392 (Montelukast sodium 10 mg (base))
Pill imprint G 392 has been identified as Montelukast sodium 10 mg (base).
Montelukast is used in the treatment of hay fever; asthma, maintenance; asthma; bronchospasm prophylaxis; copd and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 10 mg (base) is not subject to the Controlled Substances Act.
See also related documents.
Images for G 392 (Montelukast sodium 10 mg (base))
- 10 mg (base)
- Prescription only
- Drug Class:
- Leukotriene modifiers
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Glenmark Generics Inc., USA
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
hypromellose 2910 (15000 mPa.s)
ferric oxide yellow
ferric oxide red
Montelukast sodium is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...